Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes?

Results suggest that telmisartan may reduce type-I diabetes mellitus-induced hepatic injury by suppressing activated hepatic stellate cells through concomitant TGF-β1 down-regulation.